Protagenic Therapeutics, Inc.\new (PTIX) Free cash flow 2023–2026
Protagenic Therapeutics, Inc.\new (PTIX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.8MFY2026 · since FY2023: -$2.0M → -$2.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$2.8M | — |
| FY2024 | -$3.9M | -93.1% |
| FY2023 | -$2.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice